- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
CVS Health’s Theresa Juday on How Cognitive Behavioral Therapy Can Ameliorate Health Disparities
Theresa Juday, RPh, director, Specialty Product Development, CVS Health, discusses the potential of cognitive behavioral therapy to address health disparities in underserved communities.
Cognitive behavioral therapy (CBT), particularly digital CBT, has the potential to address health disparities prevalent in underserved communities nationwide, said Theresa Juday, RPh, director, Specialty Product Development, CVS Health.
Transcript
What impact may the evolution of CBT capabilities have on patient outcomes?
Not just around CBT, but in a more broader health care scope where I think for CBT or digital CBT in particular, it's important to think about how this helps to address a very important area of health care and one that we have seen conversations emerge easily in the last 5 years, and that is how we help address health disparities.
So from a digital perspective in particular, digital CBT can help to do that as well. So I talked a little bit more about addressing patients who have transportation issues or rural populations, populations where language is a barrier, that is something that all leads to health disparities. Also, people of color. The stigma around cognitive behavioral therapy as a whole in populations of color does exist, and digital CBT can help to address that concern as well.
Again, bringing it in house, they can do it in the comfort of their own home. They can make it a little bit more anonymous while still accessing the care that they need. Looking at how CBT and particularly digital CBT can not only improve health outcomes, but address some of those health disparity barriers that exist might be an important piece to the puzzle.
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
